Skip to main content
JS Link, Inc. logo

JS Link, Inc. — Investor Relations & Filings

Ticker · 127120 ISIN · KR7127120004 KO Manufacturing
Filings indexed 601 across all filing types
Latest filing 2024-12-09 Regulatory Filings
Country KR South Korea
Listing KO 127120

About JS Link, Inc.

https://en.jslink.co.kr/

JS Link, Inc. is a company with dual operations in biotechnology and advanced materials manufacturing. Formerly known as DNA Link, Inc., its biotechnology division is a genome-based research and development firm. It specializes in genomic mass analysis technology, providing sequencing and analysis services for DNA, RNA, and other genomic data to advance personalized medicine. The company also operates a division dedicated to the manufacturing of high-performance sintered permanent magnets, which are produced using rare earth materials.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a formal regulatory filing from a Korean company (DNALink) announcing the signing of a significant supply contract. It details the contract value, the counterparty (Korea Research Institute of Bioscience and Biotechnology), the duration, and the scope of work. Since this is a specific announcement of a material business event (a contract award) and does not fit into categories like financial reports, dividends, or management changes, it is classified as a general regulatory filing.
2024-12-09 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the correction of a previously announced convertible bond issuance (전환사채권 발행결정 정정신고). It details changes to the total issuance amount, use of funds, and conversion terms. This type of filing is a regulatory disclosure regarding capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2024-12-06 Korean
증권발행결과(자율공시) (제12회차 CB)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB). It details the issuance method, the amount raised, and the payment date. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2024-12-06 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'DNA Link' (디엔에이링크) covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). This is a regulatory filing concerning capital structure changes and financing activities. According to the provided definitions, documents detailing fundraising and financing activities are classified as 'Capital/Financing Update' (CAP).
2024-11-14 Korean
투자판단관련주요경영사항 (국가 통합 바이오 빅데이터 구축 사업 우선협상대상자 선정)
Regulatory Filings Classification · 1% confidence The document is a regulatory disclosure from a Korean company (DNAlink) regarding the selection as a preferred bidder for a government project. It details the contract value, the nature of the project, and its significance relative to the company's revenue. This type of disclosure is a standard regulatory filing for material business events, which does not fit into specific categories like M&A, dividends, or financial reports, thus falling under the general regulatory filing category.
2024-10-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.